Velsipity 2 mg
Velsipity 2 mg is a medicine authorised by Swissmedic under authorisation number 69377. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 September 2024 and the authorisation is limited until 09 September 2029. ATC code L04AE05 places the medicine in the group Immunosuppressants.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Velsipity 2 mg, Filmtabletten | B | 10 September 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L04AE05 | 07.15.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Velsipity 2 mg authorised in Switzerland?
Yes. Velsipity 2 mg is authorised by Swissmedic under authorisation number 69377, data as of 01 September 2026. The authorisation is limited until 09 September 2029.
Which dispensing category does Velsipity 2 mg have?
Velsipity 2 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Velsipity 2 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.